Seres Therapeutics (MCRB) Q1 2025 Earnings

Mar 13Confirmed
Q2 2024
Q3 2024
Q4 2024
Q1 2025
-3.93
-2.43
-0.92
0.58

Details

Expected EPS
-3.930115
Actual EPS
-1.8
Surprise EPS
2.13
Surprise Percent
+54.2%

Description

⁨Seres Therapeutics⁩ (⁦MCRB⁩) has reported earnings of ⁦-1.8⁩ per share for ⁦Q1 2025⁩.

0 Comments

Share your thoughts